Cargando…

Epigenetic Silencing of STAT3-Targeted miR-193a, by Constitutive Activation of JAK/STAT Signaling, Leads to Tumor Progression Through Overexpression of YWHAZ in Gastric Cancer

PURPOSE: The purpose of this study was to identify genes that were epigenetically silenced by STAT3 in gastric cancer. METHODS: MBDcap-Seq and expression microarray were performed to identify genes that were epigenetically silenced in AGS gastric cancer cell lines depleted of STAT3. Cell lines and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Kuo-Liang, Chou, Jian-Liang, Chen, Yin-Chen, Low, Jie-Ting, Lin, Guan-Ling, Liu, Jing-Lan, Chang, Te-Sheng, Chen, Wei-Ming, Hsieh, Yung-Yu, Yan, Pearlly S., Chuang, Yu-Ming, Lin, Jora M. J., Wu, Shu-Fen, Chiang, Ming-Ko, Li, Chin, Wu, Cheng-Shyong, Chan, Michael W. Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951088/ https://www.ncbi.nlm.nih.gov/pubmed/33718136 http://dx.doi.org/10.3389/fonc.2021.575667

Ejemplares similares

Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer
por: Wu, Cheng-Shyong, et al.
Publicado: (2016)

Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer
por: Yeh, Chung-Min, et al.
Publicado: (2016)

Smoking as an Independent Risk Factor for Hepatocellular Carcinoma Due to the α7-Nachr Modulating the JAK2/STAT3 Signaling Axis
por: Li, Ching-Li, et al.
Publicado: (2019)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
por: Niu, Guo-Juan, et al.
Publicado: (2018)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

Ponicidin Induces Apoptosis via JAK2 and STAT3 Signaling Pathways in Gastric Carcinoma
por: Liu, Yuan-Fei, et al.
Publicado: (2015)

Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells
por: Cao, Wei, et al.
Publicado: (2015)

A JAK/STAT invasion
por: Wells, William A.
Publicado: (2002)

JAK-STAT and bone metabolism
por: Li, Jiliang
Publicado: (2013)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

JAK-STAT in lymphoproliferative disorders
por: Rabadan, Raul, et al.
Publicado: (2015)

Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris
por: Juczynska, K., et al.
Publicado: (2020)

Effects of Di-(2-ethylhexyl) Phthalate on Lipid Metabolism by the JAK/STAT Pathway in Rats
por: Jia, Yiyang, et al.
Publicado: (2016)

Acteoside inhibits inflammatory response via JAK/STAT signaling pathway in osteoarthritic rats
por: Qiao, Zhiguang, et al.
Publicado: (2019)

A novel potential target of IL‐35‐regulated JAK/STAT signaling pathway in lupus nephritis
por: Cai, Zhe, et al.
Publicado: (2021)

Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer
por: Wei, Kuo-Liang, et al.
Publicado: (2019)

Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway
por: Yin, Qianqian, et al.
Publicado: (2021)

Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction
por: Huang, Jhy-Shrian, et al.
Publicado: (2016)

VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway
por: Zheng, Congying, et al.
Publicado: (2023)

JAK-STAT in heterochromatin and genome stability
por: Silver-Morse, Louise, et al.
Publicado: (2013)

JAK-STAT and intestinal mucosal immunology
por: Heneghan, Aaron F, et al.
Publicado: (2013)

JAK-STAT: Getting to the heart of the matter
por: Barry, Sean P.
Publicado: (2012)

JAK-STAT pathway and myogenic differentiation
por: Jang, You-Na, et al.
Publicado: (2013)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020)

JAK-STAT in Early Hematopoiesis and Leukemia
por: Fasouli, Eirini Sofia, et al.
Publicado: (2021)

JAK-STAT pathway inhibitors in dermatology()
por: Miot, Hélio Amante, et al.
Publicado: (2023)

Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway
por: Rui, Xin, et al.
Publicado: (2017)

Xanthatin inhibits STAT3 and NF‐κB signalling by covalently binding to JAK and IKK kinases
por: Liu, Man, et al.
Publicado: (2019)

Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling
por: Gajjela, Bharath Kumar, et al.
Publicado: (2022)

The JAK/STAT signaling pathway: from bench to clinic
por: Hu, Xiaoyi, et al.
Publicado: (2021)

JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
por: Huang, I-Hsin, et al.
Publicado: (2022)

Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers
por: Ni, Yanhong, et al.
Publicado: (2022)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

Regulation and therapy, the role of JAK2/STAT3 signaling pathway in OA: a systematic review
por: Chen, Bo, et al.
Publicado: (2023)

The potential roles of JAK/STAT signaling in the progression of osteoarthritis
por: Zhou, Qingluo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e38frkqhkgjd0lf7konrqs5r3c